Curtobacterium oceansedimentum Infective Endocarditis: A Plant-Associated Pathogen Causing Acute Heart Failure From Severe Valvular Dysfunction - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Curtobacterium oceansedimentum Endocarditis: A Plant-Associated Bacterium Linked to Acute Heart Failure and Severe Valve Dysfunction

  • October 20, 2026

Share

Clinical Scorecard: Curtobacterium oceansedimentum Endocarditis: A Plant-Associated Bacterium Linked to Acute Heart Failure and Severe Valve Dysfunction

At a Glance

CategoryDetail
ConditionCurtobacterium oceansedimentum infective endocarditis with severe aortic insufficiency
Key MechanismsAortic valve tissue culture identified Curtobacterium oceansedimentum despite negative blood cultures; transesophageal echocardiography showed left coronary cusp perforation.
Target PopulationA 53-year-old man with polysubstance use disorder, retained facial-fracture hardware, acute heart failure, and culture-negative endocarditis.
Care SettingHospital evaluation and treatment, including echocardiography, aortic valve replacement, tissue microbiology, and empiric antibiotic therapy.

Key Highlights

  • The authors describe this as the first documented case of Curtobacterium infective endocarditis.
  • Blood cultures remained negative; the organism was identified from intraoperative aortic valve tissue after referral to an outside laboratory.
  • The patient had severe aortic insufficiency, left coronary cusp perforation, reduced left ventricular ejection fraction, and valvular cardiogenic shock with end-organ hypoperfusion.
  • The isolate was reported sensitive to ceftriaxone.
  • The patient left rehabilitation against medical advice before completing the prescribed antibiotic therapy.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          A 53-year-old man with polysubstance use disorder presented with dyspnea, lethargy, edema, severe aortic insufficiency, and reduced ejection fraction; blood cultures were negative.

          Treatment included inotropic and afterload-reducing support, surgical bioprosthetic aortic valve replacement, and empiric vancomycin plus ceftriaxone. The isolate was subsequently identified from valve tissue and reported sensitive to ceftriaxone.

          Clinical Best Practices

          • In this case, valve tissue culture identified the organism despite negative blood cultures.
          • The report states that species-level identification required referral because the local laboratory could not identify the unusual organism.
          • The case used transthoracic and transesophageal echocardiography to assess valve structure and ventricular function.
          • The patient left rehabilitation before completing the prescribed antibiotic therapy.

          Related Resources & Content

          Original Source(s)

          Related Content